In a nutshell This study aimed to investigate if arsenic trioxide was safe and effective as a maintenance treatment for patients with acute promyelocytic leukemia. This study concluded that this maintenance treatment was safe and effective in these patients. Some background Acute promyelocytic...
Read More
In a nutshell This study aimed to investigate the safety and effectiveness of stopping nilotinib treatment in patients with chronic-phase chronic myelogenous leukemia. This study concluded that stopping nilotinib after two years of consolidation treatment was safe and effective. Some background...
Read MoreIn a nutshell This study aimed to create a safe and effective low-intensity chemotherapy treatment plan for elderly patients with AML . This is an ongoing clinical trial and so far the authors have found the therapy has been safe and effective. Some background Outcomes for elderly patients with AML in the past have not been good due to the high...
Read More
In a nutshell This study aimed to investigate the effectiveness of nilotinib (Tasigna) as a consolidation therapy for chronic myeloid leukemia patients. This study concluded that nilotinib is safe and effective as a consolidation therapy in these patients. Some background Nilotinib is a targeted therapy used to treat chronic myeloid leukemia...
Read More
In a nutshell This study examined lenalidomide (Revlimid) as a consolidation strategy in patients with chronic lymphocytic leukemia (CLL) who have residual disease after treatment. This study reported good response improvements (in 45% of patients with residual disease). Lenalidomide may be particularly suited as a consolidation strategy after...
Read More
In a nutshell This study aimed to evaluate if a clofarabine-based combination would be suitable as a post-remission chemotherapy in younger patients with acute myeloid leukemia. This study concluded that a clofarabine-based combination may be considered as a post-remission chemotherapy in younger patients with acute myeloid leukemia. Some...
Read More
